SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-032572
Filing Date
2023-07-12
Accepted
2023-07-11 20:20:11
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pkbo-20230331.htm   iXBRL 10-Q 1711722
2 EX-31.1 pkbo-ex31_1.htm EX-31.1 20381
3 EX-31.2 pkbo-ex31_2.htm EX-31.2 21358
4 EX-32.1 pkbo-ex32_1.htm EX-32.1 9112
5 EX-32.2 pkbo-ex32_2.htm EX-32.2 9081
  Complete submission text file 0000950170-23-032572.txt   7304059

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pkbo-20230331_def.xml EX-101.DEF 219175
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pkbo-20230331_lab.xml EX-101.LAB 440208
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pkbo-20230331_cal.xml EX-101.CAL 44317
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pkbo-20230331.xsd EX-101.SCH 53006
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pkbo-20230331_pre.xml EX-101.PRE 340429
63 EXTRACTED XBRL INSTANCE DOCUMENT pkbo-20230331_htm.xml XML 1201856
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

IRS No.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39951 | Film No.: 231083084
SIC: 2836 Biological Products, (No Diagnostic Substances)